Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

The global cancer immunotherapy market should reach $96.5 billion by 2021 from $73.0 billion in 2016 at a compound annual growth rate (CAGR) of 5.7%, from 2016 to 2021.

Report Includes
An overview of the global markets for cancer immunotherapies and oncolytic virology.
Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Analyses of factors influencing market demand, such as clinical guidelines, demographic changes, and market saturation.
Information covering the latest trends, market structure, market size, key drug segments, and trends in technology.
Coverage of colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines, and other cancer treatment immunology products.
Technological discussions, including the current state, newly issued patents, and pending applications.
Profiles of leading companies in the industry.

Report Scope
The scope of this report covers current cancer immunotherapy markets for most common cancers. The market segments included in this report are therapeutic monoclonal antibodies (with special focus on checkpoint inhibitors), synthetic interleukins, interferons, and colony-stimulating factors; small kinase inhibitors of cancer-related targets; protective and therapeutic cancer vaccines; and adoptive cell therapies. This report also covers treatments that are in development for late-stage and early-stage oncolytic viruses. Detailed epidemiological information, discussion of incidence and mortality trends, overview of regulatory landscapes, and analysis of market shares for leading products and companies are also included in this report.

Chapter 1 Introduction
Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of The Study
Information Sources for the Technology Assessment
Forecasting Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Summary and Highlights
Chapter 3 Overview
Past and Present of Cancer Immunology
What is Cancer?
Cancer as a Genetic Disorder
Treating Cancer
Radiation Therapy
Pharmaceutical Therapy
Challenges in Treating Cancer
Cancer and the Immune System
Towards Combination Immunotherapy
Focusing on Cell-mediated Adaptive Immunity
Fine Tuning Versus Boosting Cancer Immunity
Early Versus Advanced Stage Cancer Immunotherapy
Personalized Treatment Paradigm
Clinically Significant Types of Cancers
Lung Cancer
Breast Cancer
Colorectal Cancer
Stomach Cancer
Head and Neck Cancer
Cervical Cancer
Prostate Cancer
Melanoma of the Skin
Ovarian Cancer
Future of Checkpoint Inhibitors, Cancer Vaccines, and Oncolytic Virology
Chapter 4 Overview of Cancer Immunotherapy
Overview of Cancer Immunotherapy
Immune System and Immunotherapy
Therapeutic Monoclonal Antibodies
Checkpoint Inhibitors
Biological Response Modifiers
Interleukin Products
Colony-Stimulating Factors
Vaccines to Protect Against Cancer
Therapeutic Cancer Vaccines
VEGFR and PDGFR Inhibitors
EGFR and HER2/NEU Inhibitors
BCR-ABL Inhibitors
Proteasome Inhibitors
BTK Inhibitors
Expanded Information on Selected Product Candidates and Recent Regulatory Applications
Lartruvo (Olaratumab)
Inotuzumab Ozagamicin
Sacituzumab Govitecan (IMMU-132)
Chapter 5 Oncolytic virology
Oncolytic Virology
Oncolytic Virotherapy
T-VEC (Talimogene Laherparepvec)
PEXA-VEC (Pexastimogene Devacirepvec)
Enadenotucirev (ColoAd1)
Chapter 6 Major Markets
Major Markets
Markets for Immunotherapy Products
Markets for Oncolytic Virology Products
Chapter 7 Company Profiles
Company Profiles
Lists of Tables and Figures
About BCC Research
About BCC Research
BCC Library Access
BCC Custom Research

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook